30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Maxine Gowen

Track

Insider profile

Currently holds positions in Idera Pharmaceuticals Inc, Trevena Inc and Akebia Therapeutics Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 47% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Idera Pharmaceuticals Inc Jan. 4, 2016 -
Director Trevena Inc Oct. 1, 2018 -
Independent Director Akebia Therapeutics Inc July 28, 2014 -
President, Chief Executive Officer, Director Trevena Inc None -
Independent Director Human Genome Sciences Inc Feb. 15, 2008 - July 30, 2012
Maxine Gowen's trades of Idera Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-11 2023-08-10
S Sale
5,054 -40.5%
52.26
US$420,721 		5,054 -40.5% 52.26 US$420,721
2023-08-10 2023-08-10
PrS Proposed sale
58,926
496.46
US$1,988,208 		58,926 496.46 US$1,988,208
2020-06-09 2020-06-08
PlS Planned sale
48,668 +29.2%
203.27
US$4,302,338 		48,668 +29.2% 203.27 US$4,302,338
2019-02-05 2019-02-01
US Trevena Inc (TRVN)
B Purchase
50,000 +1250.0%
1.02
US$51,000 		50,000 +1250.0% 1.02 US$51,000